|Study Description:||The goal of this clinical research study is to evaluate the effectiveness of |
Tarceva® (OSI-774, erlotinib hydrochloride) in combination with Targretin®
(bexarotene) in treating NSCLC. The safety of this treatment will also be
studied, as well as the treatment's effect on different cells in the body and
the participants' overall response.